Jacob, PhD, Chairman and CEO, Synergy Pharmaceuticals Inc, in a news release. Synergy Pharmaceuticals is poised to present additional phase
Synergy Pharmaceuticals Inc Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. Cipher Pharmaceuticals Acquires Exclusive
Item 7.01 Regulation FD Disclosure. As previously announced, on Decem, Synergy Pharmaceuticals Inc, a Delaware corporation (the Company ) and its wholly-owned subsidiary, Synergy Advanced Pharmaceuticals, Inc, a Delaware corporation ( Synergy Advanced and together with the Company, the Debtors ) filed voluntary petitions for relief (the Chapter 11 Cases
On, Synergy Pharmaceuticals Inc. went out of business on completion of liquidation under chapter 11 bankruptcy filing. Synergy Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders.
NEW YORK, Ma /PRNewswire/ - Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the Company or Synergy ), a biopharmaceutical company focused on the development and commercialization of
A U.S. bankruptcy court approved the sale of Synergy Pharmaceuticals Inc. company Synergy for about $195 million in cash. The assets
Synergy Pharmaceuticals Secures $300 Million Debt Financing, which stated in relevant part: Synergy Pharmaceuticals Inc. (NASDAQ: SGYP)
Search SYNERGY PHARMACEUTICALS, INC. business contracts filed with the Securities and Exchange Commission.
SYNERGY PHARMACEUTICALS INC. SYNERGY PHARMACEUTICALS INC. Payments in 2024. $3.28M. payment total. 12,325. doctors receiving payments. 0. teaching hospitals
Comments
5star story.